Healthstream Inc (HSTM) · Sep 23, 2026 · Other events
Executive incentive grants — $2.88M aggregate grant-date value; 25% annual vesting through 2030
HealthStream adds long-term awards for its top team; most vest over four years, while performance shares depend on targets not yet disclosed.
HealthStream is expanding its healthcare workforce software platform toward a broader enterprise clinical workforce offering, while continuing to post growth in its core business.
This is a retention and incentive action, not a change to the operating story. Four named executives received $450,000 of time-based RSUs plus $150,000 of performance-based RSUs, while Scott Roberts received $360,000 and $120,000, respectively. The awards total $2.88 million in grant-date value across the named executive team.
The structure favors keeping the leadership team in place through the next planning cycle. The time-based awards vest 25% annually over four years, while the performance awards are tied to annual targets for 2027 through 2030 that have not yet been disclosed. 〔0〕 〔1〕
Relative to expectations, this is mostly routine compensation disclosure. It adds the specific size and long-dated performance framework, but it does not change guidance, capital allocation, strategy, or near-term execution. The main business implication is deferred compensation expense and potential future dilution, balanced against an effort to retain executives during HealthStream’s platform expansion.
Bottom line: This filing reinforces management retention but does not materially change HealthStream’s business trajectory. It is a governance and compensation update, not a new operating catalyst.
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!